Ahlstrom's comparable restated financial figures

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ahlstrom's comparable restated financial figures

Ahlstrom Corporation STOCK EXCHANGE RELEASE July 27, 2016 at 09:10

Ahlstrom's comparable restated financial figures

Ahlstrom publishes comparable restated financial figures for 2015 and January-March 2016 following the decision not to divest the company's Building & Wind business unit to Owens Corning.

The Building & Wind business unit, which had been reported in discontinued operations since the beginning of 2016, will from now on be reported as part of the Filtration & Performance segment. Ahlstrom's financial reporting is aligned with this change starting from the January-June 2016 interim report, to be published on August 3, 2016. The restated comparable financial figures for 2015 and January-March 2016 are presented in the attached file. Restatements for earlier periods have not been made.

For more information, please contact: Sakari Ahdekivi Chief Financial Officer Tel. +358 10 888 4768

Juho Erkheikki Financial Communications & Investor Relations Manager Tel. +358 10 888 4731

Ahlstrom in brief Ahlstrom provides innovative fiber-based materials with a function in everyday life. We are committed to growing and creating stakeholder value by proving the best performing sustainable fiber-based materials. Our products are used in everyday applications such as filters, medical fabrics, life science and diagnostics, wallcoverings, tapes, and food and beverage packaging. In 2015, Ahlstrom's net sales amounted to EUR 1.1 billion. Our 3,300 employees serve customers in 22 countries. Ahlstrom's share is quoted on the Nasdaq Helsinki. More information is available at  www.ahlstrom.com .

HUG#2030925

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

When to Replace Your Tucson AC for Savings

Updated Category News Views 16

Grappling with the Tucson Heat: AC Dilemmas You're smack in the middle of a blistering Tucson summer, and guess what? Your AC decides to take a dive. Happens, right? The HelloNation article, drawing on insights from HVAC expert Dan Barrios, gives the skinny on whether you should repair or replace that grumpy old unit. Understanding the Age Factor in AC Systems Here's the...

Continue Reading
H.I.G. Capital Strengthens Position with GetixHealth Investment

Updated Category News Views 492

H.I.G. Capital Completes Acquisition of GetixHealth H.I.G. Capital, a premier global alternative investment firm with a substantial portfolio valued at $68 billion, has recently announced a compelling strategic investment in GetixHealth, LLC. This collaboration marks a significant step forward in enhancing the offerings of GetixHealth in the realm of healthcare revenue...

Continue Reading
LivePerson Reports Impressive Q3 2025 Financial Performance

Updated Category News Views 197

Financial Highlights from LivePerson’s Third Quarter 2025 LivePerson, Inc. (NASDAQ: LPSN), a prominent leader in conversational AI and digital transformation, has released its financial results for the third quarter of 2025. The company achieved remarkable total revenue of $60.2 million, exceeding expectations and demonstrating its resilience in meeting customer...

Continue Reading
Deutsche Aircraft's D328eco: Revolutionizing Regional Travel

Updated Category News Views 207

The Future of Regional Aviation: Introducing the D328eco As regional airlines in the U.S. navigate the challenges of rising operational costs and workforce shortages, the need for fleet renewal becomes increasingly critical. The aviation sector faces this urgency head-on, particularly with the aging fleet of 30 to 50-seat aircraft. With significant demand for improved...

Continue Reading
Vincerx Pharma Merges with Oqory: A New Era in Oncology

Updated Category News Views 510

Vincerx Pharma Announces Strategic Merger with Oqory, Inc. Vincerx Pharma, Inc. (NASDAQ: VINC), a pioneering biopharmaceutical company dedicated to meeting the challenges faced by cancer patients, has made a bold move by entering into a strategic merger with Oqory, Inc. This partnership is filled with potential, as Oqory specializes in developing antibody-drug conjugates...

Continue Reading